Acorda Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Acorda Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Acorda Therapeutics Inc Strategy Report
- Understand Acorda Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Acorda Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
CA2890459C | Grant | ULTRA LOW DENSITY PULMONARY POWDERS | A61J3/074; A61K31/05; A61K31/137; A61K31/198; A61K47/02; A61K47/24; A61K47/38; A61K9/0073; A61K9/0075; A61K9/12; A61K9/145; A61K9/16; A61K9/1611; A61K9/1617; A61K9/4816; A61K9/4833; A61K9/4858; A61P11/06; A61P25/16; B65B1/16; B65B1/26; B65B1/36; B65B63/028 | August 23, 2022 |
EP2377536B2 | Grant | Verfahren zur Verwendung von Aminopyridinzusammensetzugnen mit verzögerter Freisetzung | A61K31/435; A61K31/44; A61K31/4409; A61K9/20; A61P17/02; A61P19/08; A61P21/00; A61P25/00; A61P25/28; A61P43/00 | August 17, 2022 |
CA2717193C | Grant | METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS | A61K38/18; A61K38/1883; A61K38/51; A61K45/06; A61K9/08; A61P25/00; A61P25/02; A61P25/28; G01N2333/4756; G01N2800/285; G01N33/6872; G01N33/6896 | August 16, 2022 |
CA2870734C | Grant | METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS | A61K31/435; A61K31/44; A61K31/4409; A61K9/20; A61P17/02; A61P19/08; A61P21/00; A61P25/00; A61P25/28; A61P43/00 | August 16, 2022 |
IL281376B | Grant | Therapeutic neuregulin peptides for the treatment of prophylaxis of heart failure | A61K31/5513; A61K38/1808; A61K38/1883; A61K9/0019; A61P43/00; A61P9/00; A61P9/04 | August 01, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer